Ivím Health is a telehealth service that specializes in personalized weight loss programs through the prescription of GLP-1 medications. Their offerings are designed to provide comprehensive, individualized care, leveraging advanced technology to ensure accessibility and effectiveness. Ivím Health aims to transform workplace wellness.
Availability
Ivím is available in 49 states (Mississippi excluded) and Washington DC.
Understanding the Ivím Health Weight Loss Program
Ivím Health's online GLP-1 weight loss program provides options that fit your lifestyle and goals. To be eligible for our compounded GLP-1 medication programs, you must be an Ivím Health member. This membership is the cornerstone of our personalized approach to weight loss and unlocks a robust support system designed to maximize your success.
It’s important to understand that GLP-1 weight loss medications, such as compounded semaglutide and compounded tirzepatide, are medical treatments, not over-the-counter products. These medications require a prescription and ongoing medical supervision to ensure safe and effective use, which is why our membership model is a vital part of our patients’ success.
Cost Structure
Ivím Health offers both monthly and 3-month program options, with additional medications available as optional add-ons. The monthly costs for GLP-1 programs at Ivím Health are structured as follows:
Read also: Weight Loss Guide Andalusia, AL
Monthly Programs:
| Name of Drug | Weekly Dose Range | Medication Cost | Membership Cost | Total Monthly Cost |
|---|---|---|---|---|
| Compounded Semaglutide | All doses | $299 | $74.99 | $373.99 |
| Compounded Tirzepatide | 2.5-5 mg | $399 | $74.99 | $473.99 |
| Compounded Tirzepatide | 7.5-10 mg | $399 | $74.99 | $473.99 |
| Compounded Tirzepatide | 12.5-15 mg | $599 | $74.99 | $673.99 |
3-Month Programs:
| Name of Drug and Weekly Dose | Medication Cost (One-Time Upfront) | Membership Cost (Monthly x3) | Total Cost for 3 Months |
|---|---|---|---|
| Compounded Semaglutide Jump Start | $525 | $224.97 | $749.97 |
| Compounded Semaglutide 1.00 mg Maintenance | $597 | $224.97 | $821.97 |
| Compounded Semaglutide 2.50 mg Maintenance | $597 | $224.97 | $821.97 |
| Compounded Semaglutide Max Dose Completion | $1497 | $224.97 | $1721.97 |
| Compounded Tirzepatide Jump Start | $897 | $224.97 | $1121.97 |
| Compounded Tirzepatide 5 mg | $897 | $224.97 | $1121.97 |
| Compounded Tirzepatide 10 mg | $997 | $224.97 | $1221.97 |
| Compounded Tirzepatide 15 mg | $1497 | $224.97 | $1721.97 |
| Compounded Tirzepatide Max Dose Completion | $1497 | $224.97 | $1721.97 |
Additional Medications (Optional Add-ons):
| Medication | Cost |
|---|---|
| Lipotropic (Fat Burner) (4 mL) | $79/month |
| Lipotropic (Fat Burner) (10 mL) | $99/month |
| Sermorelin (Body Sculpting) | $99/month |
The Ivím Health Approach to Weight Loss
Ivím Health adopts a holistic philosophy, prioritizing your overall well-being, not just medication dispensing, offering a suite of health services to support your weight loss journey comprehensively. Ivím Health’s membership functions similarly to a co-pay at a primary care provider or specialist, but it covers much more. Access to unlimited consultations with licensed healthcare experts without incurring additional fees.
Key Components of the Program
- Medical Expertise: A team of healthcare professionals provides ongoing supervision to manage your treatment safely, including regular assessments and vigilant monitoring for potential side effects.
- Personalized Treatment Plans: Ivím Health recognizes that each patient’s weight loss journey is unique.
- Technology Integration: A platform leverages cutting-edge telehealth technology to provide seamless communication, easy access to health records, and tools for tracking your progress.
- Expedited Refills: A streamlined refill system ensures your wellness journey continues without interruption.
- Quality and Safety Commitment: Ivím Health selects FDA-inspected, state-regulated compounding pharmacies that meet regulatory board standards for quality and safety to fulfill compounded GLP-1 medication prescriptions.
GLP-1 Medications and Their Role
Glucagon-like peptide-1 (GLP-1) medications have been revolutionary in the management of obesity, arming healthcare providers with an effective weight reduction therapy that can provide patients with an average weight reduction of 15 % or more. Semaglutide was initially approved for the treatment of type 2 diabetes before receiving FDA approval in 2021 for weight reduction, with an average weight reduction of up to 14.9 % of total body weight at 68 weeks.
Compounded Semaglutide and Tirzepatide
During the GLP-1 shortages of branded semaglutide, patients were provided the ability to utilize compounded semaglutide from 503A and/or 503B compounding pharmacies utilizing equivalent dosage strengths of the active pharmaceutical ingredient, if medically appropriate, to both establish care and ensure continuity of treatment.
All compounding pharmacies providing medication to Ivím Health patients are 503A or 503B compounding pharmacies based in the United States. Based on 503A/503B regulations, all manufacturers of the semaglutide active pharmaceutical ingredient would be required to have a Drug Master File (DMF) on file with the FDA in order to be utilized by a 503A/503B pharmacy.
Compounded semaglutide was self-administered by the patient through the use of insulin syringes to draw up from medication vials based upon the providers' dosing instructions. Branded semaglutide was self-administered by the patient using an auto-injector pen.
Read also: Beef jerky: A high-protein option for shedding pounds?
Zepbound®
With Ivim, you have choices - access Zepbound® in a single-dose vial or prefilled pen. Zepbound® injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of obesity.
Zepbound® works by slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, which can help manage weight when combined with diet and exercise. Coverage depends on your insurance plan and whether Zepbound® is prescribed for an FDA-approved use.
Zepbound® is FDA approved for some adults who are overweight with other weight-related medical problems, to help them lose excess body weight and keep the weight off and may be prescribed by an Ivím Health provider as part of your weight management program. Choosing a GLP-1 medication like Zepbound® depends on individual health history and insurance coverage. Your Ivím provider can help determine the best option for your weight loss journey.
Clinical Study and Results
A clinical protocol was developed to deliver Individualized Virtual Integrative Medicine (IVIM) using a telehealth model built to combat the inefficiencies that have hindered the widespread coverage of GLP-1 medications. This is built on a foundation of streamlined access to the patient's medical care team and a tech-enabled platform to enhance patient education, training, tracking, and community support.
Study Design and Patient Selection
This retrospective analysis was conducted using a database of patients enrolled with Ivim Health. Patients evaluated for inclusion in the study were across 49 states (excluding the state of Mississippi due to telehealth laws regarding medical weight reduction) and were enrolled in the clinical care protocol through the telehealth platform.
Read also: Inspiring Health Transformation
Patients were required to have a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 30 or more. Patients were not excluded for having other health conditions, attempting previous weight reduction medications, or even having previous weight reduction surgery; thus, the patient base is representative of the general population with obesity. Patients excluded from participation included those with relative or absolute contraindications to GLP-1 therapy according to the protocol.
Key Findings
Patients with obesity completing 52 weeks of the IVIM clinical protocol on semaglutide lost 19.5 % of total body weight with 47.8 % of patients losing 20 % or more.
Mean change in weight at 12-weeks for all patients was 14.9 lbs (6.5 %), 24-weeks: 28.6 lbs (12.6 %), 36-weeks: 36.8 lbs (16.4 %), 52-weeks: 45.95 lbs (19.5 %), and those who extended to 68-weeks lost: 46.9 lbs (21.8 %).
A Linear Mixed Effects Model was used to test the relationship between time spent on the IVIM protocol and weight reduction. This model estimated a weight reduction coefficient of -0.739 lbs/week, providing a large z-statistic of -74.02 and a p value < 0.0001.
The Importance of Medical Oversight
Unlike over-the-counter medications, GLP-1 medications must be prescribed by a healthcare professional. Just as you wouldn’t buy antibiotics from an unverified source because they are cheap, you shouldn’t obtain GLP-1 medications without professional medical oversight.
Patients were required to have at least quarterly check-ins with their medical provider in combination with a clinical questionnaire to determine dose titration with each refill that was provided. Patients received personalized titration while following the prescribing information for FDA approved branded semaglutide based on weight reduction results and side effects experienced during their treatment. Patients were initiated at a dosage of 0.25 mg once weekly for 4 weeks and were able to modify their dosing each month as prescribed by their medical provider. Dosage was increased to 0.5 mg, 1 mg, 1.7 mg, and up to the maximum dose of semaglutide (2.4 mg) based on the patient's tolerability and weight reduction results.
Ivím at Work: Corporate Wellness Program
Ivím Health is launching Ivím at Work. This first-of-its-kind corporate wellness program, focused on optimizing weight management and elevating employee health and productivity, is created in partnership with Xevant, a leading provider of custom data analytics and insurance claims processing solutions. Ivím Health aims to transform workplace wellness.
Dr. Jessica Cortazzo, Ivím's Medical Director and a diplomate of the American Board of Obesity Medicine (ABOM), went on to highlight, "Our approach to medical weight loss utilizes customized GLP-1 care plans that significantly improve employee biomarkers, enhance employee well-being, engagement, and company performance, while also providing significant cost savings through claims reductions and rebate programs to both employers and employees. Through the recently announced partnership with Xevant, Ivím at Work now provides real-time data to employers on program utilization, group health outcomes, and cost savings analysis.
Additional Programs and Services
GLP-1 ID
With GLP-1 ID, your care isn’t just personalized- it’s fully individualized, reflecting your body’s rhythm, your lifestyle, and your goals, one week at a time. Weekly adjustments to your dose based on your progress-so every step is tailored to you.
Women’s HRT Program
Hormonal changes don’t have to define you. Our Women’s HRT Program helps you take control of your health, energy, and confidence-at any stage.
Ivím Supplements
Physician-formulated supplements that sync with your plan and help you feel your best, inside and out.
Getting Started with Ivím Health
Your journey to a healthier you begins with Ivím Health! Schedule a free consultation with one of our healthcare providers to discuss which plan is right for you and how we can make your weight loss goals a reality. Ivím Health keeps things simple: plans start at around $74.99 per month, with no long-term contracts or hidden fees. That monthly cost covers your telehealth consults, unlimited follow-ups, treatment plan adjustments, 20% off supplements, and shipping. Want to pause or switch up your plan? It takes just a few clicks.